149 related articles for article (PubMed ID: 38175578)
1. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer.
León-Letelier RA; Dou R; Vykoukal J; Yip-Schneider MT; Maitra A; Irajizad E; Wu R; Dennison JB; Do KA; Zhang J; Schmidt CM; Hanash S; Fahrmann JF
Clin Chem; 2024 Jan; 70(1):102-115. PubMed ID: 38175578
[TBL] [Abstract][Full Text] [Related]
2. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
3. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?
Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR
Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473
[TBL] [Abstract][Full Text] [Related]
4. Role of microbiota and microbiota-derived short-chain fatty acids in PDAC.
Temel HY; Kaymak Ö; Kaplan S; Bahcivanci B; Gkoutos GV; Acharjee A
Cancer Med; 2023 Mar; 12(5):5661-5675. PubMed ID: 36205023
[TBL] [Abstract][Full Text] [Related]
5. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Mendez R; Kesh K; Arora N; Di Martino L; McAllister F; Merchant N; Banerjee S; Banerjee S
Carcinogenesis; 2020 Jul; 41(5):561-570. PubMed ID: 31369062
[TBL] [Abstract][Full Text] [Related]
6. Human microbiota colonization and pancreatic ductal carcinoma.
Fang Y; Yang G; Yang J; Ren J; You L; Zhao Y
Crit Rev Microbiol; 2023 Aug; 49(4):455-468. PubMed ID: 35924947
[TBL] [Abstract][Full Text] [Related]
7. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics.
Qian J; Zhang X; Wei B; Tang Z; Zhang B
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188943. PubMed ID: 37355177
[TBL] [Abstract][Full Text] [Related]
8. Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.
Shen X; Zhu X; Liu H; Yuan R; Guo Q; Zhao P
PLoS One; 2024; 19(4):e0302361. PubMed ID: 38687802
[TBL] [Abstract][Full Text] [Related]
9. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
Zhong H; Liu S; Zhu J; Wu L
Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
[TBL] [Abstract][Full Text] [Related]
10. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
11. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Correlation of Helical Computed Tomography (CT) Features With Pathologic Findings.
Xu W; Liu X; Zhang J; Yang L
Acad Radiol; 2017 May; 24(5):609-614. PubMed ID: 28153575
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
13. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
14. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
15. The role of microbiome in pancreatic cancer.
Li JJ; Zhu M; Kashyap PC; Chia N; Tran NH; McWilliams RR; Bekaii-Saab TS; Ma WW
Cancer Metastasis Rev; 2021 Sep; 40(3):777-789. PubMed ID: 34455517
[TBL] [Abstract][Full Text] [Related]
16. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
18. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
[TBL] [Abstract][Full Text] [Related]
19. Microbiome and pancreatic ductal adenocarcinoma.
Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
[TBL] [Abstract][Full Text] [Related]
20. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
